Refining HEPAmet for Treatment Eligibility in Metabolic Dysfunction-Associated Steatotic Liver Disease: External

Tsubasa Tsutsumil1, Takumi Kawaguchi2, Hideki Fujii3

  • 1Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Chicago, Chicago, Illinois; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.

Abstract

No abstract available in PubMed .